Evidence map›Paper›PMID 36197575›Full record

ArticleEuropean journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology2022

Comparison of infections with respiratory syncytial virus between children and adults: a multicenter surveillance from 2015 to 2019 in Beijing, China.

Ming Luo, Cheng Gong, Yan Zhang, Xue Wang, Yang Liu, Qing Luo, Maozhong Li, Aihua Li, Yiting Wang, Mei Dong and 2 more

Open access · bronzeAbstract readMulticenter Study
In one paragraph

Article in European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Observational
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Ming Luo *Institute for Immunization and Prevention, Beijing Center for Disease Prevention and Control & Beijing Research Center for Preventive Medicine, 16th Hepingli Middle Road, Dongcheng District, Beijing, 100013, China.
Cheng Gong *Institute for Immunization and Prevention, Beijing Center for Disease Prevention and Control & Beijing Research Center for Preventive Medicine, 16th Hepingli Middle Road, Dongcheng District, Beijing, 100013, China.
Yan Zhang *National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, 155th Changbai Road, Changping District, Beijing, 102206, China.
Xue WangInstitute for Immunization and Prevention, Beijing Center for Disease Prevention and Control & Beijing Research Center for Preventive Medicine, 16th Hepingli Middle Road, Dongcheng District, Beijing, 100013, China.
Yang LiuTongzhou Center for Disease Prevention and Control, 1st Luhe Middle School North Road, Tongzhou District, Beijing, 101100, China.
Qing LuoInstitute for Immunization and Prevention, Beijing Center for Disease Prevention and Control & Beijing Research Center for Preventive Medicine, 16th Hepingli Middle Road, Dongcheng District, Beijing, 100013, China.
Maozhong LiInstitute for Immunization and Prevention, Beijing Center for Disease Prevention and Control & Beijing Research Center for Preventive Medicine, 16th Hepingli Middle Road, Dongcheng District, Beijing, 100013, China.
Aihua LiInstitute for Immunization and Prevention, Beijing Center for Disease Prevention and Control & Beijing Research Center for Preventive Medicine, 16th Hepingli Middle Road, Dongcheng District, Beijing, 100013, China.
Yiting WangInstitute for Immunization and Prevention, Beijing Center for Disease Prevention and Control & Beijing Research Center for Preventive Medicine, 16th Hepingli Middle Road, Dongcheng District, Beijing, 100013, China.
Mei DongInstitute for Immunization and Prevention, Beijing Center for Disease Prevention and Control & Beijing Research Center for Preventive Medicine, 16th Hepingli Middle Road, Dongcheng District, Beijing, 100013, China.
Wenbo XuNational Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, 155th Changbai Road, Changping District, Beijing, 102206, China. wenbo_xu1@aliyun.com.
Fang HuangInstitute for Immunization and Prevention, Beijing Center for Disease Prevention and Control & Beijing Research Center for Preventive Medicine, 16th Hepingli Middle Road, Dongcheng District, Beijing, 100013, China. huangfang7032@126.com.
Beijing Center for Disease Prevention and Control · CNNational Institute for Viral Disease Control and Prevention · CN

Funding

Beijing Municipal Science and Technology Commission Z151100003915140National Major Science and Technology Projects of China 2017ZX10103004
6 · The paper itself

Abstract

The objective of this study is to investigate the epidemiological and clinical characteristics of the acute respiratory tract infections (ARTI) caused by respiratory syncytial virus (RSV) among the population of all age categories in Beijing, China. Outpatients and inpatients with ARTI were enrolled from 35 sentinel hospitals in Beijing between March 2015 and February 2019. They were interviewed and their medical records were collected using a standardized form. Their respiratory specimens were collected and tested for the nucleic acid of RSV. The RSV-positive specimens were further genotyped into RSV-A and RSV-B groups. A total of 29,923 cases were included in this study. RSV was detected in 623 (2%, 623/29923) patients, with 391 (62.8%) genotypd as RSV-A, 126 (20.2%) as RSV-B, and 106 (17.0%) untyped. The RSV epidemic season usually occurred between October and March covering approximately 90% of annual RSV infections. The RSV-infected children aged < 5 years accounted for 52.2% of the total RSV infections with cough and fever as the most common manifestations. The RSV-infected elderly adults aged ≥ 60 years have the second largest proportion (25.2%) with dyspnea and lymphocytopenia as the most common manifestations and showed an elevated rate of hospitalization, an increased rate of ICU admission, an extended length of hospital stay, and an elevated mortality compared to the RSV-infected children. The RSV infections aged ≥ 60 years old, as the second largest population of the total annual RSV infections, usually developed worse outcomes than children and should be taken seriously.

Indexed as

Respiratory Syncytial Virus, HumanRespiratory Syncytial Virus InfectionsRespiratory Tract InfectionsAdultAgedBeijingChildHospitalizationHumansInfantMiddle AgedClinical characteristicsEpidemiological characteristicsRespiratory infectionRespiratory pathogenRespiratory syncytial virusSurveillance

Identifiers

PMID36197575
PMCPMC9533982
OpenAlexW4302027187

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.